resveratrol has been researched along with everolimus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Feng, F; Li, Q; Liu, W; Liu, Y; Sun, H; Xing, S | 1 |
| Awad, E; Othman, EM; Stopper, H | 1 |
2 other study(ies) available for resveratrol and everolimus
| Article | Year |
|---|---|
p62/SQSTM1, a Central but Unexploited Target: Advances in Its Physiological/Pathogenic Functions and Small Molecular Modulators.
Topics: Animals; Atherosclerosis; Autophagy; Humans; Neurodegenerative Diseases; Osteitis Deformans; Protein Domains; Sequestosome-1 Protein; Signal Transduction; Tumor Suppressor Proteins | 2020 |
Effects of Resveratrol, Lovastatin and the mTOR-Inhibitor RAD-001 on Insulin-Induced Genomic Damage In Vitro.
Topics: Animals; Cell Survival; Cells, Cultured; Diabetes Mellitus; DNA Damage; Epithelial Cells; Everolimus; Humans; Insulin; Kidney; Lovastatin; Rats; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes; TOR Serine-Threonine Kinases | 2017 |